Veracyte
VCYT
214 hedge funds and large institutions have $2.89B invested in Veracyte in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 82 increasing their positions, 66 reducing their positions, and 53 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
24% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 66
0.87% less ownership
Funds ownership: 109.07% → 108.2% (-0.87%)
9% less funds holding
Funds holding: 235 → 214 (-21)
26% less capital invested
Capital invested by funds: $3.92B → $2.89B (-$1.03B)
36% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 53
39% less call options, than puts
Call options by funds: $847K | Put options by funds: $1.38M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$43.1M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$42.8M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$29.8M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$27.5M |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$25.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCMC
Matrix Capital Management Company
Portsmouth,
New Hampshire
|
-$160M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$39.7M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$29.5M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
-$23.8M |
| 5 |
Bank of New York Mellon
New York
|
-$21M |
VCYT Hedge Fund Activity: Q2 2021 in Review
214 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2021, worth a combined $2.89B — down 26% from $3.92B a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of VCYT and 34 opened new positions — a net loss of 19 holders — while 66 trimmed existing stakes and 82 added.
The largest buyer was ArrowMark Colorado Holdings, adding an estimated $43.1M. The largest seller was Matrix Capital Management Company, exiting entirely with an estimated $160M sold.
- 214 institutional investors held Veracyte (VCYT) as of Q2 2021, down from 235 in Q1 2021.
- Funds reported $2.89B of Veracyte stock for Q2 2021, down 26% quarter-over-quarter.
- 34 funds opened new Veracyte positions in Q2 2021 and 53 closed out, a net change of -19 holders.
- The largest Veracyte buyer in Q2 2021 was ArrowMark Colorado Holdings, an estimated $43.1M added.
- The largest Veracyte seller in Q2 2021 was Matrix Capital Management Company, an estimated $160M sold.
Based on aggregated 13F filings for Q2 2021.